Month: October 2019

New Webinar: Hepatitis B Testing and Vaccination Programs in Correctional Facilities

Please join NASTAD’s Hepatitis Testing Partnership and Hep B United on November 12, 2019 at 2:00 PM EST for a webinar to discuss efforts to increase hepatitis B testing and vaccination in correctional facilities.

In the U.S., rates of acute hepatitis B infection among adults are on the rise in many states as a consequence of the opioid crisis. Individuals at risk for hepatitis B infection and recommended for hepatitis B testing include injection-drug users, persons infected with HIV, and persons born in geographic regions with a hepatitis B prevalence of >2%, among others.

Incarcerated persons often have a disproportionate burden of infectious diseases, including hepatitis B infection. The Advisory Committee on Immunization Practices (ACIP) recommends universal hepatitis B vaccination of adults in high-risk settings including correctional facilities. In this webinar, panelists will share efforts to increase hepatitis B testing and vaccination in state jails and prisons in Maine, Oregon, and Tennessee.

Register here. 

Speakers:
Jeff Caulfield, MPH, Viral Hepatitis Prevention Coordinator, Maine Center for Disease Control and Prevention

Rebecca Lakey, RNI Viral Hepatitis Prevention Program, East Tennessee Regional Health Office, Tennessee Department of Health

Judith Leahy, MPH, Viral Hepatitis Coordinator, Public Health Division, Oregon Health Authority

Ann A. Chakwin, PhD, Health Promotion Program Coordinator, Oregon Department of Corrections

Join the Conversation on Liver Cancer Drivers and Disparities!

Please join the Global Liver Institute, American Gastroenterological Association, Hepatitis B Foundation, Hep B United, NASH kNOWledge, AAPCHO, NVHR, and NASTAD as they host a Congressional briefing titled, “Liver Cancer Drivers and Disparities.” The briefing will be held on Thursday, October 31st, from 10:30am to 12:00pm in Washington, DC (121 Cannon House Office Building).

Learn from our nation’s leading clinicians and patient advocates about the steps needed to combat the most rapidly rising cancer since 1980, and how response strategies must begin with modernizing the systems in place to better meet the needs of impacted populations.

Join the conversation on Facebook Live at www.facebook.com/hepbfoundation  on October 31, 2019 at 10:30 am Eastern Time.

Opening Remarks:
Congresswoman Nydia Velázquez (NY)

Moderator:
Donna Cryer, JD, President & CEO, Global Liver Institute (GLI), Washington, DC

Panelists:

  • Tony Villiotti, President, NASH kNOWledge, GLI A3 Patient Advocate, Pittsburgh, PA
  • Dr. Richard Sterling, MD, MSc, FACP, FACG, AGAF, FAASLD, VCU Hepatology Professor of Medicine, Chief, Section of Hepatology, Director, Viral Hepatitis, Medical Director, Department of Internal Medicine, VCU Medical School, AGA, Richmond, VA
  • Valerie Green, NVHR Patient Advocate, Lancaster, VA
  • Dr. John Groopman, PhD, Anna M. Baetjer Professor & Associate Director for Population Sciences, Joint Appointment in Oncology, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Webinar: National and State Initiatives to Prevent Hepatitis B and Liver Cancer

October is Liver Cancer Awareness Month! Did you know that in the U.S., the rates of liver cancer incidence and deaths are increasing while most other cancer rates have declined or stabilized? Please join Hep B United on October 21, 2019 at 1:00 PM EDT for a webinar to discuss the link between hepatitis B and liver cancer.

In the U.S., up to 2.2 million people are living with chronic hepatitis B infection, only 25 percent are aware of their infection, and less than 10 percent of infected individuals are able to access care and receive treatment. Left untreated, hepatitis B can lead to premature death from liver cancer or liver failure. Panelists will discuss liver cancer and its risk factors, the Centers for Disease Control and Prevention (CDC) National Comprehensive Cancer Control Program, and promising state-based initiatives and strategies for liver cancer prevention, including hepatitis B vaccination awareness and provider education activities.

Register here.

Speakers:

Behnoosh Momin, DrPH, MS, MPH, Health Scientist, CDC Division of Cancer Prevention and Control

Charlene Cariou, MHS, CPH, CHES, Health Program Manager, Comprehensive Cancer Control, Division of Public Health, Idaho Department of Health and Welfare

Jacki Chen, #justB Storyteller and Patient Advocate